Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
38 studies found for:    Open Studies | "Living Donors"
Show Display Options
Rank Status Study
21 Recruiting Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
Condition: End Stage Renal Disease
Intervention: Drug: Expanded Tregs
22 Unknown  Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes
Condition: Renal Transplantation
Intervention: Drug: TAIZ
23 Recruiting House Calls and Decision Support: Improving Access to Live Donor Transplantation
Conditions: Chronic Kidney Disease;   End-Stage Renal Disease
Interventions: Behavioral: House Calls;   Behavioral: Web-Based Patient-Centered Decision Support Intervention
24 Recruiting Adult-to-Adult Living Donor Transplant Cohort Study
Conditions: Liver Diseases;   Hepatocellular Cancer;   End Stage Liver Disease;   Hepatitis C;   Liver Cirrhosis
Intervention:
25 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF
26 Recruiting Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant (YPT)
Condition: End Stage Renal Disease
Intervention: Behavioral: Expert System Coaching
27 Recruiting A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation
Condition: Liver Transplantation
Interventions: Drug: Advagraf;   Drug: Prograf
28 Unknown  Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
Condition: Kidney Failure, Chronic
Intervention: Drug: Thymoglobulin
29 Recruiting Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation
Condition: Pediatric Liver Transplantation
Intervention: Drug: Tacrolimus
30 Recruiting RituxiMab INDuction in Renal Transplantation
Condition: Function of Renal Transplant
Interventions: Drug: Rituximab;   Drug: Tacrolimus;   Drug: Mycophenylate mofetil;   Drug: Hydrocortisone;   Drug: Prednisolone
31 Recruiting Mesenchymal Stromal Cells in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection
Intervention: Biological: Mesenchymal Stromal Cells
32 Unknown  Adrenal Function After Living Kidney Donation
Conditions: Addison Disease;   Hypoaldosteronism
Intervention: Procedure: Laparoscopic hand-assisted donor nephrectomy
33 Recruiting Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
Condition: Immune Tolerance
Intervention: Device: Immune tolerance
34 Not yet recruiting Omega 3 Lipid Emulsions and Liver Transplantation
Condition: Reduction of Graft IR With Pretreatment of Omega 3
Intervention: Dietary Supplement: SMOFLipid
35 Not yet recruiting The ONE Study ATDC Trial
Condition: Renal Failure, End Stage
Intervention: Biological: ATDC_Nantes
36 Recruiting Comparing Everolimus and Sirolimus in Renal Transplant Recipients
Condition: Renal Failure
Interventions: Drug: Everolimus;   Drug: Sirolimus
37 Unknown  Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients
Condition: Kidney Transplantation
Interventions: Drug: Rituximab;   Drug: Standard Care
38 Unknown  Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)
Condition: Disorder Related to Renal Transplantation
Intervention: Drug: N-acetyl Cysteine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page   
Indicates status has not been verified in more than two years